Validation of the oncologic effect of hepatic resection for T2 gallbladder cancer: a retrospective study

Abstract Background While extended cholecystectomy is recommended for T2 gallbladder cancer (GBC), the role of hepatic resection for T2 GBC is unclear. This study aimed to identify the necessity of hepatic resection in patients with T2 GBC. Methods Data of 81 patients with histopathologically proven...

Full description

Bibliographic Details
Main Authors: Jin-Kyu Cho, Woohyung Lee, Jae Yool Jang, Han-Gil Kim, Jae-Myung Kim, Seung-Jin Kwag, Ji-Ho Park, Ju-Yeon Kim, Taejin Park, Sang-Ho Jeong, Young-Tae Ju, Eun-Jung Jung, Young-Joon Lee, Soon-Chan Hong, Chi-Young Jeong
Format: Article
Language:English
Published: BMC 2019-01-01
Series:World Journal of Surgical Oncology
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12957-018-1556-6
_version_ 1818514096270606336
author Jin-Kyu Cho
Woohyung Lee
Jae Yool Jang
Han-Gil Kim
Jae-Myung Kim
Seung-Jin Kwag
Ji-Ho Park
Ju-Yeon Kim
Taejin Park
Sang-Ho Jeong
Young-Tae Ju
Eun-Jung Jung
Young-Joon Lee
Soon-Chan Hong
Chi-Young Jeong
author_facet Jin-Kyu Cho
Woohyung Lee
Jae Yool Jang
Han-Gil Kim
Jae-Myung Kim
Seung-Jin Kwag
Ji-Ho Park
Ju-Yeon Kim
Taejin Park
Sang-Ho Jeong
Young-Tae Ju
Eun-Jung Jung
Young-Joon Lee
Soon-Chan Hong
Chi-Young Jeong
author_sort Jin-Kyu Cho
collection DOAJ
description Abstract Background While extended cholecystectomy is recommended for T2 gallbladder cancer (GBC), the role of hepatic resection for T2 GBC is unclear. This study aimed to identify the necessity of hepatic resection in patients with T2 GBC. Methods Data of 81 patients with histopathologically proven T2 GBC who underwent surgical resection between January 1999 and December 2017 were enrolled from a retrospective database. Of these, 36 patients had peritoneal-side (T2a) tumors and 45 had hepatic-side (T2b) tumors. To identify the optimal surgical management method, T2 GBC patients were classified into the hepatic resection group (n = 44, T2a/T2b = 20/24) and non-hepatic resection group (n = 37, T2a/T2b = 16/21). The recurrence pattern and role of hepatic resection for T2 GBC were then investigated. Results Mean age of the patients was 69 (range 36–88) years, and the male-to-female ratio was 42:39 (male, 51.9%; female, 48.1%). Hepatic-side GBC had a higher rate of recurrence than peritoneal-side GBC (44.4% vs. 8.3%, p = 0.006). The most common type of recurrence in T2a GBC was para-aortic lymph node recurrence (n = 2, 5.6%); the most common types of recurrence in T2b GBC were para-aortic lymph node recurrence (n = 7, 15.6%) and intrahepatic metastasis (n = 6, 13.3%). Hepatic-side GBC patients had worse survival outcomes than peritoneal-side GBC patients (76.0% vs. 96.6%, p = 0.041). Hepatic resection had no significant treatment effect in T2 GBC patients (p = 0.272). Multivariate analysis showed that lymph node metastasis was the only significant prognostic factor (p = 0.002). Conclusions Hepatic resection is not essential for curative treatment in T2 GBC, and more systemic treatments are needed for GBC patients, particularly for those with T2b GBC.
first_indexed 2024-12-11T00:10:31Z
format Article
id doaj.art-9cef5825a68f479e88ace62a19d51bc5
institution Directory Open Access Journal
issn 1477-7819
language English
last_indexed 2024-12-11T00:10:31Z
publishDate 2019-01-01
publisher BMC
record_format Article
series World Journal of Surgical Oncology
spelling doaj.art-9cef5825a68f479e88ace62a19d51bc52022-12-22T01:28:09ZengBMCWorld Journal of Surgical Oncology1477-78192019-01-0117111110.1186/s12957-018-1556-6Validation of the oncologic effect of hepatic resection for T2 gallbladder cancer: a retrospective studyJin-Kyu Cho0Woohyung Lee1Jae Yool Jang2Han-Gil Kim3Jae-Myung Kim4Seung-Jin Kwag5Ji-Ho Park6Ju-Yeon Kim7Taejin Park8Sang-Ho Jeong9Young-Tae Ju10Eun-Jung Jung11Young-Joon Lee12Soon-Chan Hong13Chi-Young Jeong14Department of Surgery, Gyeongsang National University Hospital, Gyeongsang National University Postgraduate School of MedicineDepartment of Surgery, Gyeongsang National University Changwon Hospital, Gyeongsang National University Postgraduate School of MedicineDepartment of Surgery, Gyeongsang National University Hospital, Gyeongsang National University Postgraduate School of MedicineDepartment of Surgery, Gyeongsang National University Hospital, Gyeongsang National University Postgraduate School of MedicineDepartment of Surgery, Gyeongsang National University Hospital, Gyeongsang National University Postgraduate School of MedicineDepartment of Surgery, Gyeongsang National University Hospital, Gyeongsang National University Postgraduate School of MedicineDepartment of Surgery, Gyeongsang National University Hospital, Gyeongsang National University Postgraduate School of MedicineDepartment of Surgery, Gyeongsang National University Hospital, Gyeongsang National University Postgraduate School of MedicineDepartment of Surgery, Gyeongsang National University Changwon Hospital, Gyeongsang National University Postgraduate School of MedicineDepartment of Surgery, Gyeongsang National University Changwon Hospital, Gyeongsang National University Postgraduate School of MedicineDepartment of Surgery, Gyeongsang National University Hospital, Gyeongsang National University Postgraduate School of MedicineDepartment of Surgery, Gyeongsang National University Changwon Hospital, Gyeongsang National University Postgraduate School of MedicineDepartment of Surgery, Gyeongsang National University Hospital, Gyeongsang National University Postgraduate School of MedicineDepartment of Surgery, Gyeongsang National University Hospital, Gyeongsang National University Postgraduate School of MedicineDepartment of Surgery, Gyeongsang National University Hospital, Gyeongsang National University Postgraduate School of MedicineAbstract Background While extended cholecystectomy is recommended for T2 gallbladder cancer (GBC), the role of hepatic resection for T2 GBC is unclear. This study aimed to identify the necessity of hepatic resection in patients with T2 GBC. Methods Data of 81 patients with histopathologically proven T2 GBC who underwent surgical resection between January 1999 and December 2017 were enrolled from a retrospective database. Of these, 36 patients had peritoneal-side (T2a) tumors and 45 had hepatic-side (T2b) tumors. To identify the optimal surgical management method, T2 GBC patients were classified into the hepatic resection group (n = 44, T2a/T2b = 20/24) and non-hepatic resection group (n = 37, T2a/T2b = 16/21). The recurrence pattern and role of hepatic resection for T2 GBC were then investigated. Results Mean age of the patients was 69 (range 36–88) years, and the male-to-female ratio was 42:39 (male, 51.9%; female, 48.1%). Hepatic-side GBC had a higher rate of recurrence than peritoneal-side GBC (44.4% vs. 8.3%, p = 0.006). The most common type of recurrence in T2a GBC was para-aortic lymph node recurrence (n = 2, 5.6%); the most common types of recurrence in T2b GBC were para-aortic lymph node recurrence (n = 7, 15.6%) and intrahepatic metastasis (n = 6, 13.3%). Hepatic-side GBC patients had worse survival outcomes than peritoneal-side GBC patients (76.0% vs. 96.6%, p = 0.041). Hepatic resection had no significant treatment effect in T2 GBC patients (p = 0.272). Multivariate analysis showed that lymph node metastasis was the only significant prognostic factor (p = 0.002). Conclusions Hepatic resection is not essential for curative treatment in T2 GBC, and more systemic treatments are needed for GBC patients, particularly for those with T2b GBC.http://link.springer.com/article/10.1186/s12957-018-1556-6Gallbladder carcinomaSurgical strategiesHepatic resection
spellingShingle Jin-Kyu Cho
Woohyung Lee
Jae Yool Jang
Han-Gil Kim
Jae-Myung Kim
Seung-Jin Kwag
Ji-Ho Park
Ju-Yeon Kim
Taejin Park
Sang-Ho Jeong
Young-Tae Ju
Eun-Jung Jung
Young-Joon Lee
Soon-Chan Hong
Chi-Young Jeong
Validation of the oncologic effect of hepatic resection for T2 gallbladder cancer: a retrospective study
World Journal of Surgical Oncology
Gallbladder carcinoma
Surgical strategies
Hepatic resection
title Validation of the oncologic effect of hepatic resection for T2 gallbladder cancer: a retrospective study
title_full Validation of the oncologic effect of hepatic resection for T2 gallbladder cancer: a retrospective study
title_fullStr Validation of the oncologic effect of hepatic resection for T2 gallbladder cancer: a retrospective study
title_full_unstemmed Validation of the oncologic effect of hepatic resection for T2 gallbladder cancer: a retrospective study
title_short Validation of the oncologic effect of hepatic resection for T2 gallbladder cancer: a retrospective study
title_sort validation of the oncologic effect of hepatic resection for t2 gallbladder cancer a retrospective study
topic Gallbladder carcinoma
Surgical strategies
Hepatic resection
url http://link.springer.com/article/10.1186/s12957-018-1556-6
work_keys_str_mv AT jinkyucho validationoftheoncologiceffectofhepaticresectionfort2gallbladdercanceraretrospectivestudy
AT woohyunglee validationoftheoncologiceffectofhepaticresectionfort2gallbladdercanceraretrospectivestudy
AT jaeyooljang validationoftheoncologiceffectofhepaticresectionfort2gallbladdercanceraretrospectivestudy
AT hangilkim validationoftheoncologiceffectofhepaticresectionfort2gallbladdercanceraretrospectivestudy
AT jaemyungkim validationoftheoncologiceffectofhepaticresectionfort2gallbladdercanceraretrospectivestudy
AT seungjinkwag validationoftheoncologiceffectofhepaticresectionfort2gallbladdercanceraretrospectivestudy
AT jihopark validationoftheoncologiceffectofhepaticresectionfort2gallbladdercanceraretrospectivestudy
AT juyeonkim validationoftheoncologiceffectofhepaticresectionfort2gallbladdercanceraretrospectivestudy
AT taejinpark validationoftheoncologiceffectofhepaticresectionfort2gallbladdercanceraretrospectivestudy
AT sanghojeong validationoftheoncologiceffectofhepaticresectionfort2gallbladdercanceraretrospectivestudy
AT youngtaeju validationoftheoncologiceffectofhepaticresectionfort2gallbladdercanceraretrospectivestudy
AT eunjungjung validationoftheoncologiceffectofhepaticresectionfort2gallbladdercanceraretrospectivestudy
AT youngjoonlee validationoftheoncologiceffectofhepaticresectionfort2gallbladdercanceraretrospectivestudy
AT soonchanhong validationoftheoncologiceffectofhepaticresectionfort2gallbladdercanceraretrospectivestudy
AT chiyoungjeong validationoftheoncologiceffectofhepaticresectionfort2gallbladdercanceraretrospectivestudy